Quantcast Venaxis' APPY1 Test Passes Futility Analysis In Pivotal Clinical Study - Congoo
 
 
BIOTECH Log In
Venaxis' APPY1 Test Passes Futility Analysis in Pivotal Clinical Study
Have an interest in this Story?
Sign Up for Real-Time email updates
KRHD TV  | July 15, 2013

SOURCE Venaxis, Inc. Company Provides Clinical and Corporate Update Company to Host Conference Call and Webcast Tuesday, July 16, 2013, 8:30 a.m. ET CASTLE ROCK, Colo. The futility analysis, which consisted of an independent review of the validity, integrity, and clinical and scientific relevan...
Read Full Article   
 
Leave a Comment: You must be logged in to leave a comment     Log in | Register
 

Featured Members
Alisha Weisser Alisha Weisser
Broker - Owner
Real Estate Industry
Christopher O'Hara Christopher O'Hara
Senior Vice President
Online Marketing

  
  View more profiles

 
Access dozens of premium and subscriptions sites Free! Download now.

Advertise   |   Build a News Circle   |   Get News Briefings   |   Congoo News Home   |   Get the Netpass
About Congoo   |   Terms   |   Privacy   |   Need Help?   |   Site Map
Copyright ©2014 Congoo.com. All Rights Reserved.